- Home
- SSKN vs HOTH Comparison
SSKN vs HOTH Comparison
Compare SSKN & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSKN
- HOTH
- Stock Information
- Founded
- SSKN 1989
- HOTH 2017
- Country
- SSKN United States
- HOTH United States
- Employees
- SSKN N/A
- HOTH N/A
- Industry
- SSKN Medical/Dental Instruments
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- SSKN Health Care
- HOTH Health Care
- Exchange
- SSKN Nasdaq
- HOTH Nasdaq
- Market Cap
- SSKN 9.7M
- HOTH 8.3M
- IPO Year
- SSKN 2005
- HOTH 2019
- Fundamental
- Price
- SSKN $2.25
- HOTH $1.14
- Analyst Decision
- SSKN Strong Buy
- HOTH Strong Buy
- Analyst Count
- SSKN 1
- HOTH 3
- Target Price
- SSKN $6.00
- HOTH $4.00
- AVG Volume (30 Days)
- SSKN 7.7K
- HOTH 3.0M
- Earning Date
- SSKN 08-13-2025
- HOTH 05-12-2025
- Dividend Yield
- SSKN N/A
- HOTH N/A
- EPS Growth
- SSKN N/A
- HOTH N/A
- EPS
- SSKN N/A
- HOTH N/A
- Revenue
- SSKN $33,620,000.00
- HOTH N/A
- Revenue This Year
- SSKN $3.31
- HOTH N/A
- Revenue Next Year
- SSKN $9.67
- HOTH N/A
- P/E Ratio
- SSKN N/A
- HOTH N/A
- Revenue Growth
- SSKN 3.30
- HOTH N/A
- 52 Week Low
- SSKN $2.10
- HOTH $0.58
- 52 Week High
- SSKN $3.80
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- SSKN 41.73
- HOTH 51.11
- Support Level
- SSKN $2.20
- HOTH $1.15
- Resistance Level
- SSKN $2.43
- HOTH $1.34
- Average True Range (ATR)
- SSKN 0.10
- HOTH 0.13
- MACD
- SSKN 0.00
- HOTH -0.02
- Stochastic Oscillator
- SSKN 16.67
- HOTH 19.44
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.